{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:09:35Z","timestamp":1794535775317,"version":"4.9.1"},"reference-count":138,"publisher":"Society for Neuroscience","issue":"45","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":182,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM133421"],"award-info":[{"award-number":["R35GM133421"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT27497 and IT24847"],"award-info":[{"award-number":["IT27497 and IT24847"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neurosci."],"published-print":{"date-parts":[[2023,11,8]]},"abstract":"<jats:p>Serotonergic psychedelics, such as psilocybin and LSD, have garnered significant attention in recent years for their potential therapeutic effects and unique mechanisms of action. These compounds exert their primary effects through activating serotonin 5-HT<jats:sub>2A<\/jats:sub>receptors, found predominantly in cortical regions. By interacting with these receptors, serotonergic psychedelics induce alterations in perception, cognition, and emotions, leading to the characteristic psychedelic experience. One of the most crucial aspects of serotonergic psychedelics is their ability to promote neuroplasticity, the formation of new neural connections, and rewire neuronal networks. This neuroplasticity is believed to underlie their therapeutic potential for various mental health conditions, including depression, anxiety, and substance use disorders. In this mini-review, we will discuss how the 5-HT<jats:sub>2A<\/jats:sub>receptor activation is just one facet of the complex mechanisms of action of serotonergic psychedelics. They also interact with other serotonin receptor subtypes, such as 5-HT<jats:sub>1A<\/jats:sub>and 5-HT<jats:sub>2C<\/jats:sub>receptors, and with neurotrophin receptors (e.g., tropomyosin receptor kinase B). These interactions contribute to the complexity of their effects on perception, mood, and cognition. Moreover, as psychedelic research advances, there is an increasing interest in developing nonhallucinogenic derivatives of these drugs to create safer and more targeted medications for psychiatric disorders by removing the hallucinogenic properties while retaining the potential therapeutic benefits. These nonhallucinogenic derivatives would offer patients therapeutic advantages without the intense psychedelic experience, potentially reducing the risks of adverse reactions. Finally, we discuss the potential of psychedelics as substrates for post-translational modification of proteins as part of their mechanism of action.<\/jats:p>","DOI":"10.1523\/jneurosci.1384-23.2023","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T19:00:25Z","timestamp":1699470025000},"page":"7472-7482","source":"Crossref","is-referenced-by-count":101,"title":["Beyond the 5-HT<sub>2A<\/sub>Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action"],"prefix":"10.1523","volume":"43","author":[{"given":"Lindsay P.","family":"Cameron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8211-5642","authenticated-orcid":false,"given":"Joseph","family":"Benetatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vern","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5743-852X","authenticated-orcid":false,"given":"Emma M.","family":"Bonniwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaina M.","family":"Jaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7392-0460","authenticated-orcid":false,"given":"Rafael","family":"Moliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Castr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"McCorvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6014-2084","authenticated-orcid":false,"given":"Mikael","family":"Palner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2272-1138","authenticated-orcid":false,"given":"Argel","family":"Aguilar-Valles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"393","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"2023110811001462000_43.45.7472.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00653-6"},{"key":"2023110811001462000_43.45.7472.2","doi-asserted-by":"crossref","unstructured":"Al-Kachak A , Fulton SL , Farrelly LA , Lepack AE , Bastle RM , Kong L , Cathomas F , Newman EL , Menard C , Ramakrishnan A , Chan JC , Safovich P , Lyu Y , Covington HE , Shen L , Gleason K , Tamminga CA , Russo SJ , Maze I (2023) Histone H3 serotonylation dynamics in dorsal raphe nucleus contribute to stress-induced gene expression and behavior. bioRxiv. https:\/\/doi.org\/10.1101\/2023.05.04.539464","DOI":"10.1101\/2023.05.04.539464"},{"key":"2023110811001462000_43.45.7472.3","doi-asserted-by":"crossref","first-page":"102302","DOI":"10.1016\/j.cbpa.2023.102302","article-title":"Post-translational modifications of histone proteins by monoamine neurotransmitters","volume":"74","author":"Al-Kachak","year":"2023","journal-title":"Curr Opin Chem Biol"},{"key":"2023110811001462000_43.45.7472.4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3389\/fphar.2018.00994","article-title":"LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL\/6J Mice","volume":"9","author":"Alper","year":"2018","journal-title":"Front Pharmacol"},{"key":"2023110811001462000_43.45.7472.5","doi-asserted-by":"crossref","first-page":"1074633","DOI":"10.3389\/fphar.2022.1074633","article-title":"Psilocybin sex-dependently reduces alcohol consumption in C57BL\/6J mice","volume":"13","author":"Alper","year":"2023","journal-title":"Front Pharmacol"},{"key":"2023110811001462000_43.45.7472.6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.08.032","article-title":"Evidence for intact 5-HT1A receptor-mediated feedback inhibition following sustained antidepressant treatment in a rat model of depression","volume":"141","author":"Babb","year":"2018","journal-title":"Neuropharmacol"},{"key":"2023110811001462000_43.45.7472.7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"2023110811001462000_43.45.7472.8","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00145-4"},{"key":"2023110811001462000_43.45.7472.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.12.071"},{"key":"2023110811001462000_43.45.7472.10","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00134"},{"key":"2023110811001462000_43.45.7472.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-3008-z"},{"key":"2023110811001462000_43.45.7472.12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/acschemneuro.2c00718","article-title":"5-HT2ARs mediate therapeutic behavioral effects of psychedelic tryptamines","volume":"14","author":"Cameron","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"2023110811001462000_43.45.7472.13","doi-asserted-by":"crossref","first-page":"e00767","DOI":"10.1002\/prp2.767","article-title":"The 5-HT2C receptor as a therapeutic target for alcohol and methamphetamine use disorders: a pilot study in treatment-seeking individuals","volume":"9","author":"Campbell","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"2023110811001462000_43.45.7472.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13282-7"},{"key":"2023110811001462000_43.45.7472.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.034"},{"key":"2023110811001462000_43.45.7472.16","doi-asserted-by":"crossref","first-page":"115028","DOI":"10.1016\/j.bcp.2022.115028","article-title":"'Selective' serotonin 5-HT2A receptor antagonists","volume":"200","author":"Casey","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"2023110811001462000_43.45.7472.17","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.61"},{"key":"2023110811001462000_43.45.7472.18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fphar.2014.00116","article-title":"It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system","volume":"5","author":"Chartoff","year":"2014","journal-title":"Front Pharmacol"},{"key":"2023110811001462000_43.45.7472.19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/acs.jmedchem.5b01153","article-title":"Further advances in optimizing (2-phenylcyclopropyl)methylamines as novel serotonin 2C agonists: effects on hyperlocomotion, prepulse inhibition, and cognition models","volume":"59","author":"Cheng","year":"2016","journal-title":"J Med Chem"},{"key":"2023110811001462000_43.45.7472.20","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1021\/acs.jmedchem.6b01194","article-title":"Design and discovery of functionally selective serotonin 2C (5-HT2C) receptor agonists","volume":"59","author":"Cheng","year":"2016","journal-title":"J Med Chem"},{"key":"2023110811001462000_43.45.7472.21","unstructured":"Chrysanthos N (2023) 'It's going to be for people with money': psychedelic treatments tipped to cost at least $25,000. Sydney Morning Herald. https:\/\/www.smh.com.au\/politics\/federal\/it-s-going-to-be-for-people-with-money-psychedelic-treatments-tipped-to-cost-at-least-25-000-at-first-20230313-p5crpd.html. [Accessed June 24, 2023]."},{"key":"2023110811001462000_43.45.7472.22","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000504"},{"key":"2023110811001462000_43.45.7472.23","doi-asserted-by":"publisher","DOI":"10.1124\/mol.62.3.578"},{"key":"2023110811001462000_43.45.7472.24","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.135046"},{"key":"2023110811001462000_43.45.7472.25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"2023110811001462000_43.45.7472.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01744-z"},{"key":"2023110811001462000_43.45.7472.27","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1659-20.2020"},{"key":"2023110811001462000_43.45.7472.28","doi-asserted-by":"crossref","unstructured":"de la Fuente Revenga M , Zhu B , Guevara CA , Naler LB , Saunders JM , Zhou Z , Toneatti R , Sierra S , Wolstenholme JT , Beardsley PM , Huntley GW , Lu C , Gonz\u00e1lez-Maeso J (2021) Prolonged epigenetic and synaptic plasticity alterations following single exposure to a psychedelic in mice. bioRxiv 432725. https:\/\/doi.org\/10.1101\/2021.02.24.432725.","DOI":"10.1101\/2021.02.24.432725"},{"key":"2023110811001462000_43.45.7472.29","unstructured":"Delix Therapeutics (2023) Delix Therapeutics announces completion of 1st cohort dosing, dose escalation approval in Phase I trial for novel compound DLX-001. https:\/\/www.delixtherapeutics.com\/news\/delix-therapeutics-announces-completion-of-1st-cohort-dosing-dose-escalation-approval-in-phase-i-trial-for-novel-compound-dlx-001\/. [Accessed June 2023]."},{"key":"2023110811001462000_43.45.7472.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.03.043"},{"key":"2023110811001462000_43.45.7472.31","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","article-title":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","volume":"47","author":"D'Souza","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"2023110811001462000_43.45.7472.32","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4050"},{"key":"2023110811001462000_43.45.7472.33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41398-022-02103-9","article-title":"Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice","volume":"12","author":"Fadahunsi","year":"2022","journal-title":"Transl Psychiatry"},{"key":"2023110811001462000_43.45.7472.34","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41386-020-0663-6","article-title":"Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression","volume":"45","author":"Farmer","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"2023110811001462000_43.45.7472.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1024-7"},{"key":"2023110811001462000_43.45.7472.36","doi-asserted-by":"crossref","first-page":"109150","DOI":"10.1016\/j.neuropharm.2022.109150","article-title":"Effects of pimavanserin and lorcaserin on alcohol self-administration and reinstatement in male and female rats","volume":"215","author":"Fletcher","year":"2022","journal-title":"Neuropharmacology"},{"key":"2023110811001462000_43.45.7472.37","doi-asserted-by":"crossref","first-page":"878609","DOI":"10.3389\/fneur.2022.878609","article-title":"Hallucinogenic persisting perception disorder: a case series and review of the literature","volume":"13","author":"Ford","year":"2022","journal-title":"Front Neurol"},{"key":"2023110811001462000_43.45.7472.38","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41386-022-01279-4","article-title":"Histone H3 dopaminylation in ventral tegmental area underlies heroin-induced transcriptional and behavioral plasticity in male rats","volume":"47","author":"Fulton","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"2023110811001462000_43.45.7472.39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/epi.12923","article-title":"Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study","volume":"56","author":"Ghosh","year":"2015","journal-title":"Epilepsia"},{"key":"2023110811001462000_43.45.7472.40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.24.13473"},{"key":"2023110811001462000_43.45.7472.41","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-26-08836.2003"},{"key":"2023110811001462000_43.45.7472.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.01.008"},{"key":"2023110811001462000_43.45.7472.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"2023110811001462000_43.45.7472.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.01.108"},{"key":"2023110811001462000_43.45.7472.45","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300711"},{"key":"2023110811001462000_43.45.7472.46","first-page":"1183","article-title":"Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior","volume":"295","author":"Grottick","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"2023110811001462000_43.45.7472.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.01.017"},{"key":"2023110811001462000_43.45.7472.48","doi-asserted-by":"crossref","first-page":"107933","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"key":"2023110811001462000_43.45.7472.49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1242\/jeb.196.1.251","article-title":"Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules","volume":"196","author":"Henry","year":"1994","journal-title":"J Exp Biol"},{"key":"2023110811001462000_43.45.7472.50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023151118"},{"key":"2023110811001462000_43.45.7472.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2013.08.001"},{"key":"2023110811001462000_43.45.7472.52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00702-019-01989-y","article-title":"Classical dopamine agonists","volume":"126","author":"Horowski","year":"2019","journal-title":"J Neural Transm (Vienna)"},{"key":"2023110811001462000_43.45.7472.53","doi-asserted-by":"publisher","DOI":"10.1124\/pr.114.009514"},{"key":"2023110811001462000_43.45.7472.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.04.044"},{"key":"2023110811001462000_43.45.7472.55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.2.735"},{"key":"2023110811001462000_43.45.7472.56","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00213-022-06092-x","article-title":"Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents","volume":"239","author":"Jaster","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"2023110811001462000_43.45.7472.57","doi-asserted-by":"crossref","first-page":"113979","DOI":"10.1016\/j.bcp.2020.113979","article-title":"The selective 5-HT2A receptor agonist 25CN-NBOH: structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of 3H]25CN-NBOH","volume":"177","author":"Jensen","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"2023110811001462000_43.45.7472.58","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093587"},{"key":"2023110811001462000_43.45.7472.59","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2016.1170135"},{"key":"2023110811001462000_43.45.7472.60","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1038\/s41598-022-08085-4","article-title":"Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample","volume":"12","author":"Jones","year":"2022","journal-title":"Sci Rep"},{"key":"2023110811001462000_43.45.7472.61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0905884106"},{"key":"2023110811001462000_43.45.7472.62","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05258-z"},{"key":"2023110811001462000_43.45.7472.63","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1021\/acsmedchemlett.2c00354","article-title":"Application of deuterated N,N-dimethyltryptamine in the potential treatment of psychiatric and neurological disorders","volume":"13","author":"Kargbo","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"2023110811001462000_43.45.7472.64","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410363490"},{"key":"2023110811001462000_43.45.7472.65","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.173948"},{"key":"2023110811001462000_43.45.7472.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.024"},{"key":"2023110811001462000_43.45.7472.67","doi-asserted-by":"crossref","unstructured":"Kot EF , Goncharuk SA , Franco ML , Arseniev AS , Benito-Mart\u00ednez A , Costa M , Cattaneo A , Vilar M , Mineev KS (2023) Structural basis for the transmembrane signaling and antidepressant-induced activation of the receptor tyrosine kinase TrkB. bioRxiv 543881. https:\/\/doi.org\/10.1101\/2023.06.06.543881.","DOI":"10.1101\/2023.06.06.543881"},{"key":"2023110811001462000_43.45.7472.68","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4610-0"},{"key":"2023110811001462000_43.45.7472.69","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01177-4"},{"key":"2023110811001462000_43.45.7472.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2004.01.001"},{"key":"2023110811001462000_43.45.7472.71","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw8806"},{"key":"2023110811001462000_43.45.7472.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112203"},{"key":"2023110811001462000_43.45.7472.73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways","volume":"36","author":"L\u00f3pez-Gim\u00e9nez","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"2023110811001462000_43.45.7472.74","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.048272"},{"key":"2023110811001462000_43.45.7472.75","doi-asserted-by":"crossref","first-page":"e2208672119","DOI":"10.1073\/pnas.2208672119","article-title":"TGM2-mediated histone transglutamination is dictated by steric accessibility","volume":"119","author":"Lukasak","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023110811001462000_43.45.7472.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.01.017"},{"key":"2023110811001462000_43.45.7472.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.022"},{"key":"2023110811001462000_43.45.7472.78","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0324-9"},{"key":"2023110811001462000_43.45.7472.79","doi-asserted-by":"crossref","first-page":"e0263252","DOI":"10.1371\/journal.pone.0263252","article-title":"Updated cost-effectiveness of MDMA-assisted therapy for the treatment of post-traumatic stress disorder in the United States: findings from a Phase 3 trial","volume":"17","author":"Marseille","year":"2022","journal-title":"PLoS One"},{"key":"2023110811001462000_43.45.7472.80","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1857"},{"key":"2023110811001462000_43.45.7472.81","doi-asserted-by":"crossref","unstructured":"Mazza M , Kotzalidis GD , Marano G , De Berardis D , Martinotti G , Romagnoli E , Biondi-Zoccai G , Abbate A , Sani G (2023) Lorcaserin: worthy of further insights? Results from recent research. CNS Neurol Disord Drug Targets. Advance online publication. Retrieved Mar 30, 2023. https:\/\/doi.org\/10.2174\/1871527322666230330124137.","DOI":"10.2174\/1871527322666230330124137"},{"key":"2023110811001462000_43.45.7472.82","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-08-03531.2003"},{"key":"2023110811001462000_43.45.7472.83","doi-asserted-by":"publisher","DOI":"10.1124\/mol.62.6.1339"},{"key":"2023110811001462000_43.45.7472.84","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(80)90178-8"},{"key":"2023110811001462000_43.45.7472.85","doi-asserted-by":"crossref","first-page":"eabh2399","DOI":"10.1126\/sciadv.abh2399","article-title":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","volume":"7","author":"Meinhardt","year":"2021","journal-title":"Sci Adv"},{"key":"2023110811001462000_43.45.7472.86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuropharm.2017.01.034","article-title":"Receptor-stimulated transamidation induces activation of Rac1 and Cdc42 and the regulation of dendritic spines","volume":"117","author":"Mi","year":"2017","journal-title":"Neuropharmacol"},{"key":"2023110811001462000_43.45.7472.87","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat Neurosci"},{"key":"2023110811001462000_43.45.7472.88","doi-asserted-by":"publisher","DOI":"10.1021\/cn500329r"},{"key":"2023110811001462000_43.45.7472.89","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005315"},{"key":"2023110811001462000_43.45.7472.90","doi-asserted-by":"publisher","DOI":"10.1080\/105504901750532094"},{"key":"2023110811001462000_43.45.7472.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2003.11.002"},{"key":"2023110811001462000_43.45.7472.92","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2017.1310218"},{"key":"2023110811001462000_43.45.7472.93","doi-asserted-by":"publisher","DOI":"10.1038\/2647"},{"key":"2023110811001462000_43.45.7472.94","doi-asserted-by":"crossref","first-page":"107838","DOI":"10.1016\/j.neuropharm.2019.107838","article-title":"The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation","volume":"183","author":"Odland","year":"2021","journal-title":"Neuropharmacology"},{"key":"2023110811001462000_43.45.7472.95","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.12.197"},{"key":"2023110811001462000_43.45.7472.96","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00213-017-4545-5","article-title":"A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment","volume":"234","author":"Palacios","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"2023110811001462000_43.45.7472.97","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol Med"},{"key":"2023110811001462000_43.45.7472.98","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00514"},{"key":"2023110811001462000_43.45.7472.99","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3653"},{"key":"2023110811001462000_43.45.7472.100","doi-asserted-by":"crossref","first-page":"173500","DOI":"10.1016\/j.pbb.2022.173500","article-title":"Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice","volume":"222","author":"Qu","year":"2023","journal-title":"Pharmacol Biochem Behav"},{"key":"2023110811001462000_43.45.7472.101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009019"},{"key":"2023110811001462000_43.45.7472.102","doi-asserted-by":"publisher","DOI":"10.1038\/35092560"},{"key":"2023110811001462000_43.45.7472.103","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2014.07.017"},{"key":"2023110811001462000_43.45.7472.104","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-22-10039.2002"},{"key":"2023110811001462000_43.45.7472.105","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.155"},{"key":"2023110811001462000_43.45.7472.106","first-page":"412","article-title":"Antidepressant effects of psilocybin in the absence of psychedelic effects","volume":"59","author":"Rosenblat","year":"2023","journal-title":"Am J Psychiatry"},{"key":"2023110811001462000_43.45.7472.107","doi-asserted-by":"publisher","DOI":"10.1517\/14740330902931524"},{"key":"2023110811001462000_43.45.7472.108","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2010.02.002"},{"key":"2023110811001462000_43.45.7472.109","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3381"},{"key":"2023110811001462000_43.45.7472.110","doi-asserted-by":"crossref","first-page":"109489","DOI":"10.1016\/j.neuropharm.2023.109489","article-title":"The crosstalk between 5-HT2AR and mGluR2 in schizophrenia","volume":"230","author":"Saha","year":"2023","journal-title":"Neuropharmacology"},{"key":"2023110811001462000_43.45.7472.111","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/pha0000253","article-title":"Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats","volume":"27","author":"Sakloth","year":"2019","journal-title":"Exp Clin Psychopharmacol"},{"key":"2023110811001462000_43.45.7472.112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34055-5"},{"key":"2023110811001462000_43.45.7472.113","doi-asserted-by":"publisher","DOI":"10.1124\/pr.116.012484"},{"key":"2023110811001462000_43.45.7472.114","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000219761.05466.43"},{"key":"2023110811001462000_43.45.7472.115","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2021.06.008"},{"key":"2023110811001462000_43.45.7472.116","doi-asserted-by":"crossref","first-page":"108988","DOI":"10.1016\/j.neuropharm.2022.108988","article-title":"Sex-specific role for serotonin 5-HT2A receptor in modulation of opioid-induced antinociception and reward in mice","volume":"209","author":"Sierra","year":"2022","journal-title":"Neuropharmacology"},{"key":"2023110811001462000_43.45.7472.117","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051000"},{"key":"2023110811001462000_43.45.7472.118","doi-asserted-by":"crossref","first-page":"e13040","DOI":"10.1111\/adb.13040","article-title":"The serotonin 2C receptor agonist lorcaserin, alone and in combination with the opioid receptor antagonist naltrexone, attenuates binge-like ethanol drinking","volume":"26","author":"Tabbara","year":"2021","journal-title":"Addict Biol"},{"key":"2023110811001462000_43.45.7472.119","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00435"},{"key":"2023110811001462000_43.45.7472.120","doi-asserted-by":"publisher","DOI":"10.1038\/374542a0"},{"key":"2023110811001462000_43.45.7472.121","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.133348"},{"key":"2023110811001462000_43.45.7472.122","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00710-9"},{"key":"2023110811001462000_43.45.7472.123","doi-asserted-by":"publisher","DOI":"10.1038\/35079077"},{"key":"2023110811001462000_43.45.7472.124","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.727117"},{"key":"2023110811001462000_43.45.7472.125","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf0435"},{"key":"2023110811001462000_43.45.7472.126","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/ejn.13572","article-title":"A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents","volume":"45","author":"Vargas-Perez","year":"2017","journal-title":"Eur J Neurosci"},{"key":"2023110811001462000_43.45.7472.127","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050952"},{"key":"2023110811001462000_43.45.7472.128","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-020-0367-2"},{"key":"2023110811001462000_43.45.7472.129","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199812010-00024"},{"key":"2023110811001462000_43.45.7472.130","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2010.00036"},{"key":"2023110811001462000_43.45.7472.131","doi-asserted-by":"publisher","DOI":"10.1126\/science.1123432"},{"key":"2023110811001462000_43.45.7472.132","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2023110811001462000_43.45.7472.133","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19970203)378:1<135::AID-CNE8>3.0.CO;2-5"},{"key":"2023110811001462000_43.45.7472.134","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jad.2023.04.105","article-title":"How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change","volume":"334","author":"Zeifman","year":"2023","journal-title":"J Affect Disord"},{"key":"2023110811001462000_43.45.7472.135","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41386-021-00955-1","article-title":"Restoring glutamate homeostasis in the nucleus accumbens via endocannabinoid-mimetic drug prevents relapse to cocaine seeking behavior in rats","volume":"46","author":"Zhang","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"2023110811001462000_43.45.7472.136","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf4291"},{"key":"2023110811001462000_43.45.7472.137","first-page":"20m13699","article-title":"The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J Clin Psychiary"},{"key":"2023110811001462000_43.45.7472.138","doi-asserted-by":"crossref","unstructured":"Zheng Q , Bastle RM , Zhao S , Kong L , Vostal L , Ramakrishnan A , Shen L , Fulton SL , Wang H , Zhang B , Upad A , Thompson RE , Molina H , Stransky S , Sidoli S , Muir TW , Li H , David Y , Maze I (2022) Histone monoaminylation dynamics are regulated by a single enzyme and promote neural rhythmicity. bioRxiv 519310. https:\/\/doi.org\/10.1101\/2022.12.06.519310.","DOI":"10.1101\/2022.12.06.519310"}],"container-title":["The Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.1384-23.2023","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.1384-23.2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T19:04:01Z","timestamp":1699470241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jneurosci.org\/lookup\/doi\/10.1523\/JNEUROSCI.1384-23.2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":138,"journal-issue":{"issue":"45","published-online":{"date-parts":[[2023,11,8]]},"published-print":{"date-parts":[[2023,11,8]]}},"alternative-id":["10.1523\/JNEUROSCI.1384-23.2023"],"URL":"https:\/\/doi.org\/10.1523\/jneurosci.1384-23.2023","relation":{},"ISSN":["0270-6474","1529-2401"],"issn-type":[{"value":"0270-6474","type":"print"},{"value":"1529-2401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]}}}